What are the active and inactive ingredients of the topical medication Fucibet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fucibet Ingredients

Fucibet contains two active ingredients: betamethasone valerate 0.1% and fusidic acid 2%. 1

Active Pharmaceutical Ingredients

The combination formulation provides:

  • Betamethasone valerate 0.1% - a potent topical corticosteroid with anti-inflammatory, anti-pruritic, and vasoconstrictive properties
  • Fusidic acid 2% - a topical antibiotic highly active against Staphylococcus aureus (including methicillin-resistant strains) and other Gram-positive bacteria 2, 3

Formulation Types

Fucibet is available in multiple formulations:

  • Standard cream - for weeping or moist skin conditions 1
  • Ointment - for dry skin conditions 1
  • Lipid cream (Fucicort Lipid cream) - a newer lipid-enriched formulation that provides enhanced moisturizing and emollient effects in addition to the antibacterial and anti-inflammatory activities 2, 4

Inactive Ingredients

While the specific inactive ingredients (excipients) vary by formulation, the lipid cream contains a specially formulated lipid-enriched base designed to provide powerful emollient and moisturizing effects 2. The standard formulations contain typical cream or ointment bases, though exact excipient lists are not detailed in the available evidence.

Clinical Context

This combination is classified as a potent corticosteroid/antimicrobial preparation and is particularly useful for treating infected inflammatory skin conditions, especially clinically infected atopic dermatitis where both inflammation and bacterial infection (typically S. aureus) need to be addressed simultaneously 1, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.